Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026)
Minerva Neurosciences' (NERV) quarterly Cash from Financing Activities came in at $1.1 million in Q1 2026, down 98.55% on a QoQ basis from $74.5 million in Q4 2025.
Powered by 
Analysis
Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Minerva Neurosciences (NERV) has 12 years of Cash from Financing Activities data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.5 million (changed N/A YoY) and the FY2025 annual result came in at $74.5 million, changed N/A from the prior year.
- Cash from Financing Activities declined to $1.1 million in Q1 2026, from $74.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $74.5 million in Q4 2025 to a low of -$86691.0 in Q3 2023.
- A 3-year average of $19.0 million and a median of $1.1 million in 2026 frame the typical range for Cash from Financing Activities.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.42 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -6.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -273.15 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - | 10.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.17 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 74.50 Mn |
| Sep 30, 2025 | -45,166.00 |
| Sep 30, 2023 | -86,691.00 |
| Jun 30, 2023 | 19.69 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Mar 31, 2020 | 797,629.00 |
| Dec 31, 2019 | -1.00 |
| Mar 31, 2019 | 525,000.00 |
| Dec 31, 2018 | 165,105.00 |
| Sep 30, 2018 | -907,243.00 |
| Jun 30, 2018 | -1.31 Mn |
| Mar 31, 2018 | -1.29 Mn |
| Dec 31, 2017 | -1.27 Mn |
| Sep 30, 2017 | 40.97 Mn |
| Jun 30, 2017 | -970,415.00 |
| Mar 31, 2017 | 8.44 Mn |